HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,343,071 | -12.1% | 218,405 | -17.0% | 0.10% | -2.0% |
| Q2 2023 | $9,489,585 | +133858.0% | 263,088 | +41.8% | 0.10% | +30.3% |
| Q1 2023 | $7,084 | -33.4% | 185,502 | -0.7% | 0.08% | -36.1% |
| Q4 2022 | $10,631 | -99.9% | 186,854 | -2.0% | 0.12% | +32.2% |
| Q3 2022 | $7,538,000 | +2681.5% | 190,707 | +1323.2% | 0.09% | +1400.0% |
| Q4 2017 | $271,000 | +16.3% | 13,400 | 0.0% | 0.01% | +20.0% |
| Q3 2017 | $233,000 | +35.5% | 13,400 | 0.0% | 0.01% | +25.0% |
| Q2 2017 | $172,000 | -1.1% | 13,400 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $174,000 | -47.3% | 13,400 | -59.9% | 0.00% | -50.0% |
| Q4 2016 | $330,000 | +17.9% | 33,400 | +51.8% | 0.01% | +166.7% |
| Q1 2014 | $280,000 | – | 22,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |